RSS Feeds
Search

Articles

Pharmalicensing brings you advice, commentary and analysis from industry experts.

Articles

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Transitional Cell Cancer - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Epidemiology: Renal Cell Cancer – Incident cases set to soar
Mar 2011 - 29 pages - $3,800
Non-Small Cell Lung Cancer - Pipeline Review, Q1 2011
Feb 2011 - 538 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Mar 2008 - 250 pages - $3,995
US Oncology, Inc. - Strategy and SWOT Report
Jun 2011 - 34 pages - $125
Small-Cell Lung Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 81 pages - $1,000
Epidemiology: Non-Small Cell Lung Cancer – Despite global efforts to stop smoking, incidence rates will remain unchanged
Nov 2011 - 48 pages - $5,700
More Related Market Research Reports >>>

Your selection

Industry sector
Research tools del
Cell lines del
Therapeutic target
Oncology del
Womb cancer del
Year
2011 del

Browse By

Therapeutic target
Endometrial cancer
Papillary serous carcinoma
Uterine cancer

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us